Answers are grounded in this paper and cite their sources.
We provide a generalizable approach of using size-transformable artificial antigen-presenting cells for cancer immunotherapy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: